Nikolas K. Haass

Zitiert von

	Alle	Seit 2019
Zitate	8714	3858
h-index	45	35
i10-index	85	76

800

400

200

600

2005200620072008200920102011201220132014201520162017201820192020202120222023202438 86 105 154 261 295 397 386 483 470 507 473 534 545 583 781 747 671 553 519

Öffentlicher Zugriff

Alle anzeigen

64 Artikel

5 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Helmut SchaiderThe University of QueenslandBestätigte E-Mail-Adresse bei uq.edu.au
Nethia Mohana KumaranSenior Lecturer, School of Biological Sciences, Universiti Sains MalaysiaBestätigte E-Mail-Adresse bei usm.my
DINOOP RAVINDRAN MENONUniversity of Colorado Denver, Anshutz Medical campusBestätigte E-Mail-Adresse bei cuanschutz.edu
Peter HerseyBestätigte E-Mail-Adresse bei sydney.edu.au
Clemens KreplerMerck& CoBestätigte E-Mail-Adresse bei merck.com
Peter GunningUniversity of New South WalesBestätigte E-Mail-Adresse bei unsw.edu.au
Shweta TikooMedical University of ViennaBestätigte E-Mail-Adresse bei meduniwien.ac.at
Mitchell FanePostdoctoral Fellow, Johns Hopkins School of Public HealthBestätigte E-Mail-Adresse bei jhu.edu
Adam McCluskeyUniversity of NewcastleBestätigte E-Mail-Adresse bei newcastle.edu.au
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalBestätigte E-Mail-Adresse bei sswahs.nsw.gov.au
Katherine L NathansonProfessor of Medicine, Perelman School of Medicine at the University of PennsylvaniaBestätigte E-Mail-Adresse bei upenn.edu
Galina SchevzovResearch FellowBestätigte E-Mail-Adresse bei unsw.edu.au
Herbert TreutleinSanoosa Pty. Ltd.Bestätigte E-Mail-Adresse bei sanoosa.com
Soyer HPChair in Dermatology, The University of Queensland, Frazer InstituteBestätigte E-Mail-Adresse bei uq.edu.au
Xu Dong ZhangProfessor, School of Medicine and Public Health, University of Newcastle, AustraliaBestätigte E-Mail-Adresse bei newcastle.edu.au
yazi keBestätigte E-Mail-Adresse bei mq.edu.au
Eric MeggersProfessor of Chemistry, Philipps University Marburg (Germany)Bestätigte E-Mail-Adresse bei chemie.uni-marburg.de
Amadeus GladbachUNSW AustraliaBestätigte E-Mail-Adresse bei unsw.edu.au
Thomas FathProfessor, Macquarie UniversityBestätigte E-Mail-Adresse bei mq.edu.au
Stuart GallagherSenior Research Officer, Centenary Institute, Sydney. Melanoma Institute of Australia. University ofBestätigte E-Mail-Adresse bei sydney.edu.au

Folgen

Nikolas K. Haass

Professor for Cutaneous Oncology

Bestätigte E-Mail-Adresse bei uq.edu.au

Cutaneous Oncology


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity J Tsai, JT Lee, W Wang, J Zhang, H Cho, S Mamo, R Bremer, S Gillette, ... Proceedings of the National Academy of Sciences 105 (8), 3041-3046, 2008	1640	2008
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases KSM Smalley, NK Haass, PA Brafford, M Lioni, KT Flaherty, M Herlyn Molecular cancer therapeutics 5 (5), 1136-1144, 2006	523	2006
Adhesion, migration and communication in melanocytes and melanoma NK Haass, KSM Smalley, L Li, M Herlyn Pigment cell research 18 (3), 150-159, 2005	516	2005
Normal human melanocyte homeostasis as a paradigm for understanding melanoma NK Haass, M Herlyn Journal of Investigative Dermatology Symposium Proceedings 10 (2), 153-163, 2005	289	2005
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells KSM Smalley, R Contractor, NK Haass, AN Kulp, GE Atilla-Gokcumen, ... Cancer research 67 (1), 209-217, 2007	278	2007
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when … NK Haass, K Sproesser, TK Nguyen, R Contractor, CA Medina, ... Clinical Cancer Research 14 (1), 230-239, 2008	273	2008
Targeting glutamine transport to suppress melanoma cell growth Q Wang, KA Beaumont, NJ Otte, J Font, CG Bailey, M van Geldermalsen, ... International journal of cancer 135 (5), 1060-1071, 2014	248	2014
The role of altered cell–cell communication in melanoma progression NK Haass, KSM Smalley, M Herlyn Journal of molecular histology 35, 309-318, 2004	229	2004
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells JR Stehn, NK Haass, T Bonello, M Desouza, G Kottyan, H Treutlein, ... Cancer research 73 (16), 5169-5182, 2013	205	2013
PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas JT Lee, L Li, PA Brafford, M Van Den Eijnden, MB Halloran, K Sproesser, ... Pigment cell & melanoma research 23 (6), 820-827, 2010	199	2010
Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion KSM Smalley, P Brafford, NK Haass, JM Brandner, E Brown, M Herlyn The American journal of pathology 166 (5), 1541-1554, 2005	189	2005
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival EF Lee, TJ Harris, S Tran, M Evangelista, S Arulananda, T John, ... Cell death & disease 10 (5), 342, 2019	175	2019
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study FJ Moloney, P Guitera, E Coates, NK Haass, K Ho, R Khoury, ... JAMA dermatology 150 (8), 819-827, 2014	157	2014
Microenvironment-driven dynamic heterogeneity and phenotypic plasticity as a mechanism of melanoma therapy resistance F Ahmed, NK Haass Frontiers in oncology 8, 173, 2018	149	2018
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery KSM Smalley, M Lioni, K Noma, NK Haass, M Herlyn Expert opinion on drug discovery 3 (1), 1-10, 2008	146	2008
A stress-induced early innate response causes multidrug tolerance in melanoma D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, ... Oncogene 34 (34), 4448-4459, 2015	143	2015
Real‐time cell cycle imaging during melanoma growth, invasion, and drug response NK Haass, KA Beaumont, DS Hill, A Anfosso, P Mrass, MA Munoz, ... Pigment cell & melanoma research 27 (5), 764-776, 2014	142	2014
Modeling Melanoma In Vitro and In Vivo KA Beaumont, N Mohana-Kumaran, NK Haass Healthcare 2 (1), 27-46, 2013	132	2013
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737 KM Lucas, N Mohana-Kumaran, D Lau, XD Zhang, P Hersey, DC Huang, ... Clinical cancer research 18 (3), 783-795, 2012	125	2012
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels KSM Smalley, R Contractor, NK Haass, JT Lee, KL Nathanson, ... British journal of cancer 96 (3), 445-449, 2007	106	2007

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren